Bristol-Myers: Analysts' Upgrades, Downgrades
NEW YORK (
) --
CHANGE IN RATINGS
Abbott Laboratories
(ABT) - Get Report
downgraded at Goldman from Buy to Neutral. $59 price target. Valuation call, as BMY appears more attractive in the near term.
Ann Taylor
(ANN)
upgraded at Goldman to Buy. $25 price target. Sales finally appear to be turning around.
Bristol-Myers
(BMY) - Get Report
upgraded at Goldman to Buy. $30 price target. Company has a solid showing at ASCO and has a robust pipeline.
Celgene
(CELG) - Get Report
upgraded at Jefferies from Hold to Buy. $63 price target. Stock is down 18% since March, and the company is seeing good feedback from ASCO.
Chico's FAS
(CHS) - Get Report
downgraded at Goldman to Sell. Business turnaround appears to be leveling off. $10 price target.
Stocks Under $5 Top 10 Buy-Rated Stocks Under $5 |
Cisco Systems
(CSCO) - Get Report
upgraded at Auriga from Hold to Buy. $27 price target. Estimates also boosted, as the company appears positioned well in datacenter.
Dun & Bradstreet
(DNB)
initiated at Piper Jaffray. Initiated with a Neutral rating and $80 price target. Introduces 2010 EPS estimates of $5.50.
Brinker International
(EAT) - Get Report
downgraded at Morgan Stanley from Equal-weight to Underweight. Estimates also cut, as lower-priced casual dining restaurants could lag peers in a recovery. $17 price target.
Imax
TST Recommends
(IMAX) - Get Report
upgraded at Morgan Joseph to Buy. $21 price target. Valuation call, as theater growth should accelerate.
Intuit
(INTU) - Get Report
rated new Buy at UBS. $43 price target. Company is seeing renewed growth momentum.
National Oilweill Varco
(NOV) - Get Report
upgraded at Credit Suisse to Outperform from Neutral on improving floating rid orders. Price target trimmed by a dollar to $49.
Tyco Electronics
(TEL) - Get Report
downgraded at Ticonderoga from Buy to Neutral. Consumer-oriented portfolio has higher potential downside risk in the coming quarters.
STOCK COMMENTS / EPS CHANGES
Autodesk
(ADSK) - Get Report
cut from Conviction Buy List at Goldman. $35 price target. Stock may struggle, given higher fears of macro deceleration.
Ford
(F) - Get Report
estimates higher at Credit Suisse. 2010, 2011, and 2012 EPS estimates increased to $1.13, 1.22, and $1.33, respectively. Maintain Underperform rating and $10 price target.
First Solar
(FSLR) - Get Report
price target trimmed at Barclays. FSLR price target cut to $126 from $150. Currency weakness offset by better than expected fundamentals. Maintain Equal Weight rating.
Navistar
(NAV) - Get Report
estimates, target raised at Goldman. Shares of NAV now seen reaching $55. Estimates also increased, as orders have seen a sharp recovery over the past two months. Neutral rating.
Nasdaq
estimates increased at Goldman through 2012. Company is buying back stock faster than expected. Buy rating.
Occidental Petroleum
(OXY) - Get Report
target upped at Collins Stewart. Shares of OXY now seen reaching $91. Company should generate better production growth, while keeping a lid on costs. Hold rating.
This article was written by a staff member of TheStreet.com.
